- Pharma
- March 19, 2025
- 362 views
USV Joins Empagliflozin generic contest, launches its brand Xenia
New Delhi: One of India’s leading anti-diabetic players, USV, has become the latest entrant in the Empagliflozin generic contest with the launch of its version, Xenia, in India. The Indian drug maker…
You Missed
NCB seizes Rs 9.2 crore assets of ‘prime accused’ in transnational drugs trafficking case from Noida

NCB seizes Rs 9.2 crore assets of ‘prime accused’ in transnational drugs trafficking case from Noida
